BioCorRx Inc. (BICX) stock
BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
$0.25+0.00 (0.00%)
Close on Oct 19, 2026Market cap $7.30MP/E –Yield –
BioCorRx revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
BioCorRx's revenue for the twelve months ending Sep 30, 2025 was $948.36K, up 3464.9% year over year. For fiscal 2025 it was $797.24K, up 10301.1% from the year before. Over ten years it grew -1.5% a year on average. The highest annual figure on record is $1.17M in fiscal 2014.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $797.24K | +10301.1% |
| FY2024 | Dec 31, 2024 | $7.67K | -91.4% |
| FY2023 | Dec 31, 2023 | $89.16K | -58.3% |
| FY2022 | Dec 31, 2022 | $213.84K | +343.0% |
| FY2021 | Dec 31, 2021 | $48.27K | -60.6% |
| FY2020 | Dec 31, 2020 | $122.62K | -49.0% |
| FY2019 | Dec 31, 2019 | $240.26K | -36.2% |
| FY2018 | Dec 31, 2018 | $376.66K | -42.7% |
| FY2017 | Dec 31, 2017 | $657.27K | -6.3% |
| FY2016 | Dec 31, 2016 | $701.77K | -24.1% |
| FY2015 | Dec 31, 2015 | $924.73K | -21.0% |
| FY2014 | Dec 31, 2014 | $1.17M | +63.8% |
| FY2013 | Dec 31, 2013 | $714.96K | -17.6% |
| FY2012 | Dec 31, 2012 | $868.16K | +12.5% |
| FY2011 | Dec 31, 2011 | $771.76K | +434.5% |
| FY2010 | Dec 31, 2010 | $144.40K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $87.97K | -34.8% |
| Q1 FY2026 | Mar 31, 2026 | $214.54K | – |
| Q3 FY2025 | Sep 30, 2025 | $635.22K | – |
| Q2 FY2025 | Jun 30, 2025 | $178.24K | +4306.4% |
| Q1 FY2025 | Mar 31, 2025 | $134.90K | +3626.5% |
| Q4 FY2024 | Dec 31, 2024 | $0 | -100.0% |
| Q3 FY2024 | Sep 30, 2024 | $0 | -100.0% |
| Q2 FY2024 | Jun 30, 2024 | $4.05K | -79.4% |
| Q1 FY2024 | Mar 31, 2024 | $3.62K | -91.0% |
| Q4 FY2023 | Dec 31, 2023 | $18.94K | -7.7% |
| Q3 FY2023 | Sep 30, 2023 | $10.15K | -58.7% |
| Q2 FY2023 | Jun 30, 2023 | $19.64K | +93.9% |
| Q1 FY2023 | Mar 31, 2023 | $40.44K | +82.0% |
| Q1 FY2022 | Mar 31, 2022 | $20.52K | -31.2% |
| Q2 FY2021 | Sep 30, 2021 | $24.54K | -27.2% |
| Q1 FY2021 | Mar 31, 2021 | $10.12K | -72.6% |
| Q4 FY2020 | Dec 31, 2020 | $22.22K | -64.4% |
| Q3 FY2020 | Sep 30, 2020 | $29.81K | -36.0% |
| Q2 FY2020 | Jun 30, 2020 | $33.70K | -48.9% |
| Q1 FY2020 | Mar 31, 2020 | $36.90K | -43.5% |
| Q4 FY2019 | Dec 31, 2019 | $62.45K | +20.8% |
| Q3 FY2019 | Sep 30, 2019 | $46.56K | -40.8% |
| Q2 FY2019 | Jun 30, 2019 | $65.98K | -33.1% |
| Q1 FY2019 | Mar 31, 2019 | $65.27K | -55.8% |
| Q4 FY2018 | Dec 31, 2018 | $51.67K | -68.7% |
| Q3 FY2018 | Sep 30, 2018 | $78.58K | -46.8% |
| Q2 FY2018 | Jun 30, 2018 | $98.67K | -53.1% |
| Q1 FY2018 | Mar 31, 2018 | $147.72K | +10.1% |
| Q4 FY2017 | Dec 31, 2017 | $164.91K | +42.3% |
| Q3 FY2017 | Sep 30, 2017 | $147.59K | -11.9% |
| Q2 FY2017 | Jun 30, 2017 | $210.54K | +12.0% |
| Q1 FY2017 | Mar 31, 2017 | $134.23K | -41.7% |
| Q4 FY2016 | Dec 31, 2016 | $115.85K | +58.1% |
| Q3 FY2016 | Sep 30, 2016 | $167.60K | – |
| Q2 FY2016 | Jun 30, 2016 | $187.91K | – |
| Q1 FY2016 | Mar 31, 2016 | $230.41K | – |
| Q4 FY2015 | Dec 31, 2015 | $73.30K | – |
See a number that looks wrong?